September 18th, 2018
•Here, we present a protocol for the synthesis of placental chondroitin sulfate A binding peptide (plCSA-BP)-conjugated lipid-polymer nanoparticles via single-step sonication and bioconjugate techniques. These particles constitute a novel tool for the targeted delivery of therapeutics to most human tumors and placental trophoblasts to treat cancers and placental disorders.
Related Videos
Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells
Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles
Characterization of Tumor Cells Using a Medical Wire for Capturing Circulating Tumor Cells: A 3D Approach Based on Immunofluorescence and DNA FISH
Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts
Enrichment and Characterization of the Tumor Immune and Non-immune Microenvironments in Established Subcutaneous Murine Tumors
Establishment and Characterization of Small Bowel Neuroendocrine Tumor Spheroids
Isolation and Characterization of Patient-derived Pancreatic Ductal Adenocarcinoma Organoid Models
Generation of Orthotopic Pancreatic Tumors and Ex vivo Characterization of Tumor-Infiltrating T Cell Cytotoxicity
In Vivo Targeting of Xenografted Human Cancer Cells with Functionalized Fluorescent Silica Nanoparticles in Zebrafish
Characterization and Functional Prediction of Bacteria in Ovarian Tissues
Copyright © 2024 MyJoVE Corporation. 판권 소유